Boguski MS, Elshourbagy N, Taylor JM, Gordon JI (1984) Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Proc. Natl. Acad. Sci. USA 81:5021–5025.

Boyles J (1984) The use of primary amines to improve glutaraldehyde fixation. In: The Science of Biological Specimen Preparation for Microscopy and Microanalysis (Revel J-P, Barnard T, Haggis GH, eds) Scanning Electron Microscopy, AMF O'Hare, IL, pp 7–21.

Boyles J (1984) The use of mordants and osmium to stain lipids. Bull. Electron Microsc. Soc. Am. 14:73–76.

Chapman MJ, Innerarity TL, Arnold KS, Mahley RW (1984) In vitro apo-B,E receptor binding and in vivo catabolism of trypsin-modified low density lipoproteins. In: Latent Dyslipoproteinemias and Atherosclerosis (de Gennes JL, Polonovski J, Paoletti R, eds) Raven Press, New York, pp 93–99.

Drake TA, Rodgers GM, Sande MA (1984) Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J. Clin. Invest. 73:1750–1753.

Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL (1984) Role of apolipoprotein E in the lipolytic conversion of b-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA 81:5566–5570.

Forgez P, Chapman MJ, Rall SC Jr, Camus M-C (1984) The lipid transport system in the mouse, Mus musculus: Isolation and characterization of apolipoproteins B, A-I, A-II, and C-III. J. Lipid Res. 25:954–966.

Fox JEB, Boyles JK, Reynolds CR, Phillips DR (1984) Actin filament content and organization in unstimulated platelets. J. Cell Biol. 98:1985–1991.

Funke H, Boyles J, Weisgraber KH, Ludwig EH, Hui DY, Mahley RW (1984) Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells. Arteriosclerosis 4:452–461.

George JN, Nurden AT, Phillips DR (1984) Molecular defects in interactions of platelets with the vessel wall. N. Engl. J. Med. 311:1084–1098.

Hui DY, Innerarity TL, Mahley RW (1984) Defective hepatic lipoprotein receptor binding of b-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E. J. Biol. Chem. 259:860–869.

Hui DY, Innerarity TL, Milne RW, Marcel YL, Mahley RW (1984) Binding of chylomicron remnants and b-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J. Biol. Chem. 259:15060–15068.

Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW (1984) Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Metabolism 33:186–195.

Innerarity TL, Weisgraber KH, Arnold KS, Rall SC Jr, Mahley RW (1984) Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. J. Biol. Chem. 259:7261–7267.

Joyce NC, DeCamilli P, Boyles J (1984) Pericytes, like vascular smooth muscle cells, are immunocytochemically positive for cyclic GMP-dependent protein kinase. Microvasc. Res. 28:206–219.

Mahley RW, Angelin B (1984) Type III hyperlipoproteinemia: Recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv. Intern. Med. 29:385–411.

Mahley RW, Innerarity TL, Rall SC, Jr., Weisgraber KH (1984) Plasma lipoproteins: Apolipoprotein structure and function. J. Lipid Res. 25:1277–1294.

McLean JW, Elshourbagy NA, Chang DJ, Mahley RW, Taylor JM (1984) Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J. Biol. Chem. 259:6498–6504.

Menzel H-J, Assmann G, Rall SC Jr, Weisgraber KH, Mahley RW (1984) Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. J. Biol. Chem. 259:3070–3076.

Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW (1984) Structure and function of apolipoprotein E: Existence of multiple E2 alleles in type III hyperlipoproteinemia. In: Latent Dyslipoproteinemias and Atherosclerosis (de Gennes JL, Polonovski J, Paoletti R, eds) Raven Press, New York, pp 157–163.

Rall SC Jr, Weisgraber KH, Mahley RW, Ogawa Y, Fielding CJ, Utermann G, Haas J, Steinmetz A, Menzel H-J, Assmann G (1984) Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted. J. Biol. Chem. 259:10063–10070.

Steinmetz A, Utermann G, Haas J, Menzel HJ, Rall SC Jr, Weisgraber KH, Mahley RW (1984) Mutations of apolipoprotein AI can affect cofactor function for cholesteryl ester formation by lecithin:cholesterol acyltransferase. In: Cologne Atherosclerosis Conference No. 2: Lipids (Parnham MJ, ed) Birkhäuser Verlag, Basel, pp 217–224.

Utermann G, Haas J, Steinmetz A, Paetzold R, Rall SC, Jr. , Weisgraber KH, Mahley RW (1984) Apolipoprotein A-I_Giessen (Pro¹⁴³→Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase. Eur. J. Biochem. 144:325–331.

Utermann G, Weisgraber KH, Weber W, Mahley RW (1984) Genetic polymorphism of apolipoprotein E: A variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. J. Lipid Res. 25:378–382.

Vannice JL, Taylor JM, Ringold GM (1984) Glucocorticoid-mediated induction of a₁-acid glycoprotein: Evidence for hormone-regulated RNA processing. Proc. Natl. Acad. Sci. USA 81:4241–4245.

Weisgraber KH, Rall SC Jr, Innerarity TL, Mahley RW, Kuusi T, Ehnholm C (1984) A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. J. Clin. Invest. 73:1024–1033.

TOP